PALVELLA THERAPEUTICS, INC. - Common Stock, $0.01 par value (PVLA)

CUSIP: 697947109

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
11,842,870
Total 13F shares
5,123,397
Share change
+1,090,282
Total reported value
$143,404,590
Price per share
$27.99
Number of holders
40
Value change
+$33,701,617
Number of buys
23
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 697947109?
CUSIP 697947109 identifies PVLA - PALVELLA THERAPEUTICS, INC. - Common Stock, $0.01 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PALVELLA THERAPEUTICS, INC. - Common Stock, $0.01 par value (PVLA) as of Q1 2025

As of 31 Mar 2025, PALVELLA THERAPEUTICS, INC. - Common Stock, $0.01 par value (PVLA) was held by 40 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,123,397 shares. The largest 10 holders included SUVRETTA CAPITAL MANAGEMENT, LLC, BVF INC/IL, Frazier Life Sciences Management, L.P., SAMSARA BIOCAPITAL, LLC, ADAMS STREET PARTNERS LLC, MILLENNIUM MANAGEMENT LLC, Nantahala Capital Management, LLC, Woodline Partners LP, Opaleye Management Inc., and Blue Owl Capital Holdings LP. This page lists 40 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.